Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Blessings sir!
Well, I never got in. Thought it might of seen upper twos today. Watched it go up 30% though. Got in AMC for some reason. Glad someone made some money here.
I thought I was going to take a loss on my bottom feeding expedition, but instead I am thankful that He blesses me!
Finally sold some greened up.
I wait until the issues aren’t deaths
These guys are getting hammered! 75%
Down 75% this should be wild today!
Took a starter, gotta gave a bounce here.
I’m with ya on entry..planning on a $3ish handle which equals cash on balance sheet( ~ $185mm ish)…. Will do starter in low $4’s(minor $$, then DCA if $3’s ( much more $) …back up truck if deaths not related to clinical’s after internal investigation)
Well, 5 fatalities ready didn't help...geez...Looking for entry
Lets do this . Can it keep going
MGNX $10.71 +1.48 (+16.03%)
Nice steady climb, as shorts writhe and wail
MGNX I'm going with this
$10.50 +1.27 (+13.76%)
It's a bit of a bail, as I have other work to catch up on
Squeeze of 13% short, on a Citi upgrade to $13
Could turn into a several days hold, for incremental gains. Maybe 5% more today??
https://stockcharts.com/h-sc/ui?s=MGNX
Citigroup Upgrades Macrogenics to Buy, Raises Price Target to $13
BENZINGA 4:20 AM ET Dec-20-2023
Citigroup analyst Yigal Nochomovitz upgrades Macrogenics (MGNX.NaE) from Neutral to Buy and raises the price target from $7 to $13.
Company Profile
SectorHealth CareOpens in a new window
IndustryBiotechnologyOpens in a new window
Company LocationRockville, MD
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 x CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. In addition, i
Historic short interest:
You can go to this link to check short interest in a stock:
http://nasdaqtrader.com/Trader.aspx?id=ShortInterest
Publication schedule is here:
http://nasdaqtrader.com/Trader.aspx?id=ShortIntPubSch
Settlement Date/Short Interest/Percent Change/
Average Daily Share Volume/Days to Cover
01/13/2023 4,373,837 5.28 507,089 8.63
12/30/2022 4,154,346 7.91 575,736 7.22
12/15/2022 3,849,672 (5.66) 633,050 6.08
11/30/2022 4,080,607 (4.36) 1,384,683 2.95
11/15/2022 4,266,434 (15.78) 1,093,099 3.90
10/31/2022 5,065,570 2.50 1,487,531 3.41
10/14/2022 4,942,015 (0.29) 379,450 13.02
09/30/2022 4,956,490 1.85 563,681 8.79
09/15/2022 4,866,500 (0.81) 635,807 7.65
08/31/2022 4,905,995 (13.08) 631,036 7.77
08/15/2022 5,644,366 (0.09) 971,172 5.81
07/29/2022 5,649,639 (17.42) 1,065,799 5.30
07/15/2022 6,841,233 (10.73) 1,407,012 4.86
06/30/2022 7,663,135 (0.99) 2,692,200 2.85
06/15/2022 7,739,527 27.13 1,239,553 6.24
05/31/2022 6,088,004 8.28 827,523 7.36
05/13/2022 5,622,390 10.78 1,337,461 4.20
04/29/2022 5,075,315 3.20 453,486 11.19
04/14/2022 4,917,910 (4.48) 509,771 9.65
03/31/2022 5,148,635 3.46 522,723 9.85
03/15/2022 4,976,392 36.20 868,105 5.73
02/28/2022 3,653,830 4.57 898,618 4.07
02/15/2022 3,494,052 19.83 571,075 6.12
01/31/2022 2,915,828 7.17 457,915 6.37
So what exactly did MGNX do to this diabetes drug?
Now I need to figure out what DART and TRIDENT are...
$MGNX: What did I tell ya........ hit $4.15 !!!!!!!!!
MUAHHHHhhhhhhhhhh ha ha ha ha ha haaaaaaaaaAAAAAAAAAAAAAA
LOVE IT when a plan comes together like that
Looking for more winners............ stand by
GO $MGNX
$MGNX: Perfeccccccttttttttt Cup & Handle here at 3.50
Added 10k shares here
Get to $4 !!!!!!!!
GOO $MGNX
Where do we go from here?
SCAM ALERT, be careful the SEC must be looking at it as we speak.
This is a $13-$16 stock at best.
* * $MGNX Video Chart 05-11-2020 * *
Link to Video - click here to watch the technical chart video
$MGNX:
Nice to see shorts getting killed here.
Go ahead short some more you cowards.
* * $MGNX Video Chart 05-07-2020 * *
Link to Video - click here to watch the technical chart video
+$$$ MGNX
Successful lifestyle enhancement trading.....
* * $MGNX Video Chart 05-06-2020 * *
Link to Video - click here to watch the technical chart video
Investors are forward looking, especially into company pipeline.
We all ran with this from earlier today. Shorts will have their cluster rama rally now. GLTY.
This is going to be great IMO
Followers
|
13
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
94
|
Created
|
10/30/13
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |